|4Feb 16, 5:30 PM ET

Charych Deborah H. 4

4 · Skye Bioscience, Inc. · Filed Feb 16, 2023

Insider Transaction Report

Form 4
Period: 2023-02-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-14+250,000250,000 total
    Exercise: $0.04Exp: 2033-02-14Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]1. The option grant shall be exercisable for a price of $0.039 per option share for ten years from February 14, 2023 and the options will vest in equal monthly installments over the one year period beginning February 15, 2023.

Documents

1 file
  • 4
    wf-form4_167658660353462.xmlPrimary

    FORM 4